In the last 12 months, insiders at VERTEX PHARMACEUTICALS INC / MA ($VRTX) filed 461 transactions with the SEC: 4 open-market purchases totaling $5,844,183 and 164 sales totaling $256,682,203. Net insider sentiment: net selling.
VERTEX PHARMACEUTICALS INC / MA operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Kewalramani Reshma (CEO & President) — 43 transactions totaling $103,004,729
- LEIDEN JEFFREY M (Executive Chairman) — 48 transactions totaling $96,204,190
- Sachdev Amit (EVP Chief Patient & Ext Af Off) — 40 transactions totaling $56,401,811
- Arbuckle Stuart A (EVP, COO) — 21 transactions totaling $39,431,239
- Tatsis Ourania (EVP, Chief Reg. & Quality Off.) — 41 transactions totaling $30,107,478
View all SEC Filings for VERTEX PHARMACEUTICALS INC / MA (VRTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Liu Joy | EVP and Chief Legal Officer | S | Common Stock | 978 | $449.17 | 21,833.0000 | 258,000,000 | 4.29% | 0.00% |
| March 27, 2026 | Bozic Carmen | EVP and CMO | S | Common Stock | 2329 | $450.95 | 33,076.0000 | 258,000,000 | 6.58% | 0.00% |
| March 13, 2026 | Bozic Carmen | EVP and CMO | S | Common Stock | 2329 | $481.79 | 35,405.0000 | 258,000,000 | 6.17% | 0.00% |
| March 11, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | Common Stock | 2633 | $498.42 | 12,489.0000 | 258,000,000 | 17.41% | 0.00% |
| March 4, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | Common Stock | 2437 | $475.30 | 15,122.0000 | 258,000,000 | 13.88% | 0.00% |
| March 2, 2026 | Liu Joy | EVP and Chief Legal Officer | S | Common Stock | 892 | $495.96 | 22,811.0000 | 258,000,000 | 3.76% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 5995 | $496.16 | 100,003.0000 | 258,000,000 | 5.66% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 3498 | $494.33 | 121,578.0000 | 258,000,000 | 2.80% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 2520 | $493.29 | 125,076.0000 | 258,000,000 | 1.97% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 949 | $491.30 | 127,596.0000 | 258,000,000 | 0.74% | 0.00% |
| Feb. 27, 2026 | Bozic Carmen | EVP and CMO | S | Common Stock | 2329 | $480.31 | 37,734.0000 | 258,000,000 | 5.81% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 15580 | $495.38 | 105,998.0000 | 258,000,000 | 12.81% | 0.01% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 400 | $479.75 | 137,878.0000 | 258,000,000 | 0.29% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 120 | $481.50 | 137,758.0000 | 258,000,000 | 0.09% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 240 | $482.84 | 137,518.0000 | 258,000,000 | 0.17% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 2510 | $487.13 | 135,008.0000 | 258,000,000 | 1.83% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 3278 | $488.27 | 131,730.0000 | 258,000,000 | 2.43% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 460 | $489.32 | 131,270.0000 | 258,000,000 | 0.35% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 2725 | $490.54 | 128,545.0000 | 258,000,000 | 2.08% | 0.00% |
| Feb. 27, 2026 | Kewalramani Reshma | CEO & President | S | Common Stock | 1725 | $496.95 | 98,278.0000 | 258,000,000 | 1.72% | 0.00% |
| Feb. 26, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 357 | $483.36 | 6,624.0000 | 258,000,000 | 5.11% | 0.00% |
| Feb. 24, 2026 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1144 | $485.11 | 14,604.0000 | 258,000,000 | 7.26% | 0.00% |
| Feb. 24, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | F | Common Stock | 1744 | $485.11 | 47,042.0000 | 258,000,000 | 3.57% | 0.00% |
| Feb. 24, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 1627 | $485.11 | 47,023.0000 | 258,000,000 | 3.34% | 0.00% |
| Feb. 25, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 260 | $486.35 | 46,763.0000 | 258,000,000 | 0.55% | 0.00% |
| Feb. 24, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 1518 | $485.11 | 67,599.0000 | 258,000,000 | 2.20% | 0.00% |
| Feb. 25, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 1846 | $486.35 | 65,753.0000 | 258,000,000 | 2.73% | 0.00% |
| Feb. 24, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | F | Common Stock | 873 | $485.11 | 22,469.0000 | 258,000,000 | 3.74% | 0.00% |
| Feb. 25, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | Common Stock | 2500 | $486.35 | 19,969.0000 | 258,000,000 | 11.13% | 0.00% |
| Feb. 25, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | S | Common Stock | 2410 | $489.00 | 17,559.0000 | 258,000,000 | 12.07% | 0.00% |
| Feb. 24, 2026 | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 3547 | $485.11 | 35,237.0000 | 258,000,000 | 9.15% | 0.00% |
| Feb. 24, 2026 | Kewalramani Reshma | CEO & President | F | Common Stock | 4981 | $485.11 | 138,278.0000 | 258,000,000 | 3.48% | 0.00% |
| Feb. 24, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | F | Common Stock | 582 | $485.11 | 7,904.0000 | 258,000,000 | 6.86% | 0.00% |
| Feb. 25, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | Common Stock | 620 | $486.35 | 7,284.0000 | 258,000,000 | 7.84% | 0.00% |
| Feb. 24, 2026 | Bozic Carmen | EVP and CMO | F | Common Stock | 1453 | $485.11 | 40,063.0000 | 258,000,000 | 3.50% | 0.00% |
| Feb. 25, 2026 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 945 | $486.35 | 13,659.0000 | 258,000,000 | 6.47% | 0.00% |
| Feb. 24, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1627 | $485.11 | 19,100.0000 | 258,000,000 | 7.85% | 0.00% |
| Feb. 25, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 668 | $486.35 | 18,432.0000 | 258,000,000 | 3.50% | 0.00% |
| Feb. 24, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 546 | $485.11 | 7,204.0000 | 258,000,000 | 7.05% | 0.00% |
| Feb. 25, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 223 | $486.35 | 6,981.0000 | 258,000,000 | 3.10% | 0.00% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | M | Stock Option (Right to Buy) | 25026 | $0.00 | 0.0000 | 258,000,000 | 100.00% | 0.01% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | M | Stock Option (Right to Buy) | 23479 | $0.00 | 0.0000 | 258,000,000 | 100.00% | 0.01% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 4237 | $471.43 | 69,117.0000 | 258,000,000 | 5.78% | 0.00% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 11712 | $470.54 | 73,354.0000 | 258,000,000 | 13.77% | 0.00% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 7241 | $469.61 | 85,066.0000 | 258,000,000 | 7.84% | 0.00% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 19662 | $468.57 | 92,307.0000 | 258,000,000 | 17.56% | 0.01% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 10263 | $467.75 | 111,969.0000 | 258,000,000 | 8.40% | 0.00% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 1848 | $465.80 | 122,232.0000 | 258,000,000 | 1.49% | 0.00% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 2730 | $465.05 | 124,080.0000 | 258,000,000 | 2.15% | 0.00% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 920 | $463.91 | 126,810.0000 | 258,000,000 | 0.72% | 0.00% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | M | Common Stock | 25026 | $187.53 | 127,730.0000 | 258,000,000 | 24.37% | 0.01% |
| Feb. 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | M | Common Stock | 23479 | $155.57 | 102,704.0000 | 258,000,000 | 29.64% | 0.01% |
| Feb. 17, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 5789 | $0.00 | 81,365.0000 | 258,000,000 | 7.66% | 0.00% |
| Feb. 17, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | A | Common Stock | 7365 | $0.00 | 51,080.0000 | 258,000,000 | 16.85% | 0.00% |
| Feb. 17, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | F | Common Stock | 2294 | $483.75 | 48,786.0000 | 258,000,000 | 4.49% | 0.00% |
| Feb. 17, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 5789 | $0.00 | 51,921.0000 | 258,000,000 | 12.55% | 0.00% |
| Feb. 17, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2294 | $483.75 | 49,627.0000 | 258,000,000 | 4.42% | 0.00% |
| Feb. 17, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 609 | $489.46 | 49,018.0000 | 258,000,000 | 1.23% | 0.00% |
| Feb. 18, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 638 | $473.68 | 7,750.0000 | 258,000,000 | 7.61% | 0.00% |
| Feb. 17, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 1557 | $489.46 | 8,388.0000 | 258,000,000 | 15.66% | 0.00% |
| Feb. 17, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 598 | $483.75 | 9,945.0000 | 258,000,000 | 5.67% | 0.00% |
| Feb. 17, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 1809 | $0.00 | 10,543.0000 | 258,000,000 | 20.71% | 0.00% |
| Feb. 18, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 817 | $473.68 | 20,727.0000 | 258,000,000 | 3.79% | 0.00% |
| Feb. 17, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 2031 | $489.46 | 21,544.0000 | 258,000,000 | 8.62% | 0.00% |
| Feb. 17, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1530 | $483.75 | 23,575.0000 | 258,000,000 | 6.09% | 0.00% |
| Feb. 17, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 4962 | $0.00 | 25,105.0000 | 258,000,000 | 24.63% | 0.00% |
| Feb. 18, 2026 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 1244 | $473.68 | 15,748.0000 | 258,000,000 | 7.32% | 0.00% |
| Feb. 17, 2026 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 2476 | $489.46 | 16,992.0000 | 258,000,000 | 12.72% | 0.00% |
| Feb. 17, 2026 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1505 | $483.75 | 19,468.0000 | 258,000,000 | 7.18% | 0.00% |
| Feb. 17, 2026 | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 4135 | $0.00 | 20,973.0000 | 258,000,000 | 24.56% | 0.00% |
| Feb. 17, 2026 | Bozic Carmen | EVP and CMO | F | Common Stock | 1912 | $483.75 | 41,516.0000 | 258,000,000 | 4.40% | 0.00% |
| Feb. 17, 2026 | Bozic Carmen | EVP and CMO | A | Common Stock | 5375 | $0.00 | 43,428.0000 | 258,000,000 | 14.13% | 0.00% |
| Feb. 18, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | Common Stock | 1182 | $473.68 | 8,486.0000 | 258,000,000 | 12.23% | 0.00% |
| Feb. 17, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | Common Stock | 2437 | $489.46 | 9,668.0000 | 258,000,000 | 20.13% | 0.00% |
| Feb. 17, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | F | Common Stock | 1110 | $483.75 | 12,105.0000 | 258,000,000 | 8.40% | 0.00% |
| Feb. 17, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | A | Common Stock | 2584 | $0.00 | 13,215.0000 | 258,000,000 | 24.31% | 0.00% |
| Feb. 17, 2026 | Kewalramani Reshma | CEO & President | F | Common Stock | 6554 | $483.75 | 143,259.0000 | 258,000,000 | 4.37% | 0.00% |
| Feb. 17, 2026 | Kewalramani Reshma | CEO & President | A | Common Stock | 16326 | $0.00 | 149,813.0000 | 258,000,000 | 12.23% | 0.01% |
| Feb. 18, 2026 | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 2964 | $483.75 | 38,784.0000 | 258,000,000 | 7.10% | 0.00% |
| Feb. 17, 2026 | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 8269 | $0.00 | 41,748.0000 | 258,000,000 | 24.70% | 0.00% |
| Feb. 17, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | F | Common Stock | 1148 | $483.75 | 23,342.0000 | 258,000,000 | 4.69% | 0.00% |
| Feb. 17, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | A | Common Stock | 4962 | $0.00 | 24,490.0000 | 258,000,000 | 25.41% | 0.00% |
| Feb. 17, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2140 | $483.75 | 79,225.0000 | 258,000,000 | 2.63% | 0.00% |
| Feb. 18, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 368 | $473.68 | 48,650.0000 | 258,000,000 | 0.75% | 0.00% |
| Feb. 13, 2026 | Bhatia Sangeeta N. | Director | S | Common Stock | 266 | $500.00 | 4,299.0000 | 258,000,000 | 5.83% | 0.00% |
| Feb. 13, 2026 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 988 | $499.00 | 16,838.0000 | 258,000,000 | 5.54% | 0.00% |
| Feb. 13, 2026 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 2993 | $487.76 | 17,826.0000 | 258,000,000 | 14.38% | 0.00% |
| Feb. 13, 2026 | Bozic Carmen | EVP and CMO | F | Common Stock | 3804 | $487.76 | 38,053.0000 | 258,000,000 | 9.09% | 0.00% |
| Feb. 13, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | F | Common Stock | 2283 | $487.76 | 10,631.0000 | 258,000,000 | 17.68% | 0.00% |
| Feb. 13, 2026 | Kewalramani Reshma | CEO & President | F | Common Stock | 13041 | $487.76 | 133,487.0000 | 258,000,000 | 8.90% | 0.01% |
| Feb. 13, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | F | Common Stock | 2283 | $487.76 | 19,528.0000 | 258,000,000 | 10.47% | 0.00% |
| Feb. 13, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 3548 | $487.76 | 75,576.0000 | 258,000,000 | 4.48% | 0.00% |
| Feb. 13, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 1500 | $499.99 | 46,132.0000 | 258,000,000 | 3.15% | 0.00% |
| Feb. 13, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 3804 | $487.76 | 47,632.0000 | 258,000,000 | 7.40% | 0.00% |
| Feb. 13, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | F | Common Stock | 4565 | $487.76 | 43,715.0000 | 258,000,000 | 9.46% | 0.00% |
| Feb. 13, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 1393 | $487.76 | 8,734.0000 | 258,000,000 | 13.76% | 0.00% |
| Feb. 13, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1903 | $487.76 | 20,143.0000 | 258,000,000 | 8.63% | 0.00% |
| Feb. 11, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 1751 | $460.43 | 22,046.0000 | 258,000,000 | 7.36% | 0.00% |
| Feb. 10, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 872 | $468.41 | 23,797.0000 | 258,000,000 | 3.53% | 0.00% |
| Feb. 11, 2026 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 1925 | $460.43 | 20,819.0000 | 258,000,000 | 8.46% | 0.00% |
| Feb. 10, 2026 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1630 | $468.41 | 22,744.0000 | 258,000,000 | 6.69% | 0.00% |
| Feb. 10, 2026 | Bozic Carmen | EVP and CMO | F | Common Stock | 2145 | $468.41 | 41,857.0000 | 258,000,000 | 4.87% | 0.00% |
| Feb. 11, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S | Common Stock | 2021 | $460.43 | 12,914.0000 | 258,000,000 | 13.53% | 0.00% |
| Feb. 10, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | F | Common Stock | 1127 | $468.41 | 14,935.0000 | 258,000,000 | 7.02% | 0.00% |
| Feb. 10, 2026 | Kewalramani Reshma | CEO & President | F | Common Stock | 8297 | $468.41 | 146,528.0000 | 258,000,000 | 5.36% | 0.00% |
| Feb. 10, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | F | Common Stock | 3045 | $468.41 | 48,280.0000 | 258,000,000 | 5.93% | 0.00% |
| Feb. 10, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2140 | $468.41 | 51,902.0000 | 258,000,000 | 3.96% | 0.00% |
| Feb. 11, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 466 | $460.43 | 51,436.0000 | 258,000,000 | 0.90% | 0.00% |
| Feb. 10, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2057 | $468.41 | 79,124.0000 | 258,000,000 | 2.53% | 0.00% |
| Feb. 10, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | F | Common Stock | 1127 | $468.41 | 21,811.0000 | 258,000,000 | 4.91% | 0.00% |
| Feb. 11, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 1376 | $460.43 | 10,127.0000 | 258,000,000 | 11.96% | 0.00% |
| Feb. 10, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 592 | $468.41 | 11,503.0000 | 258,000,000 | 4.89% | 0.00% |
| Jan. 22, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 7866 | $0.00 | 50,159.0000 | 258,000,000 | 18.60% | 0.00% |
| Jan. 22, 2026 | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 3328 | $0.00 | 34,477.0000 | 258,000,000 | 10.68% | 0.00% |
| Jan. 22, 2026 | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 7866 | $0.00 | 31,149.0000 | 258,000,000 | 33.78% | 0.00% |
| Jan. 22, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 1300 | $0.00 | 12,095.0000 | 258,000,000 | 12.04% | 0.00% |
| Jan. 22, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 2950 | $0.00 | 10,795.0000 | 258,000,000 | 37.60% | 0.00% |
| Jan. 22, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 3883 | $0.00 | 24,669.0000 | 258,000,000 | 18.68% | 0.00% |
| Jan. 22, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 3934 | $0.00 | 20,786.0000 | 258,000,000 | 23.34% | 0.00% |
| Jan. 22, 2026 | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 2774 | $0.00 | 24,374.0000 | 258,000,000 | 12.84% | 0.00% |
| Jan. 22, 2026 | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 6294 | $0.00 | 21,600.0000 | 258,000,000 | 41.12% | 0.00% |
| Jan. 22, 2026 | Bozic Carmen | EVP and CMO | A | Common Stock | 3467 | $0.00 | 44,002.0000 | 258,000,000 | 8.55% | 0.00% |
| Jan. 22, 2026 | Bozic Carmen | EVP and CMO | A | Common Stock | 7866 | $0.00 | 40,535.0000 | 258,000,000 | 24.08% | 0.00% |
| Jan. 22, 2026 | Kewalramani Reshma | CEO & President | A | Common Stock | 11885 | $0.00 | 154,825.0000 | 258,000,000 | 8.31% | 0.00% |
| Jan. 22, 2026 | Kewalramani Reshma | CEO & President | A | Common Stock | 26972 | $0.00 | 142,940.0000 | 258,000,000 | 23.26% | 0.01% |
| Jan. 22, 2026 | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 9012 | $0.00 | 33,479.0000 | 258,000,000 | 36.83% | 0.00% |
| Jan. 22, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | A | Common Stock | 2080 | $0.00 | 22,938.0000 | 258,000,000 | 9.97% | 0.00% |
| Jan. 22, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | A | Common Stock | 4720 | $0.00 | 20,858.0000 | 258,000,000 | 29.25% | 0.00% |
| Jan. 22, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 3883 | $0.00 | 81,181.0000 | 258,000,000 | 5.02% | 0.00% |
| Jan. 22, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 7866 | $0.00 | 77,298.0000 | 258,000,000 | 11.33% | 0.00% |
| Jan. 22, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 3883 | $0.00 | 54,042.0000 | 258,000,000 | 7.74% | 0.00% |
| Jan. 22, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | A | Common Stock | 4160 | $0.00 | 51,325.0000 | 258,000,000 | 8.82% | 0.00% |
| Jan. 22, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | A | Common Stock | 9440 | $0.00 | 47,165.0000 | 258,000,000 | 25.02% | 0.00% |
| Jan. 15, 2026 | Upadhyay Suketu | Director | A | Deferred Stock Units | 80 | $443.56 | 2,718.6480 | 258,000,000 | 3.04% | 0.00% |
| Jan. 15, 2026 | SACHS BRUCE I | Director | A | Deferred Stock Units | 107 | $443.56 | 15,564.5210 | 258,000,000 | 0.69% | 0.00% |
| Jan. 7, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 4500 | $474.99 | 42,293.0000 | 258,000,000 | 9.62% | 0.00% |
| Jan. 6, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | M | Stock Option (Right to Buy) | 9532 | $0.00 | 0.0000 | 258,000,000 | 100.00% | 0.00% |
| Jan. 6, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | S | Common Stock | 9532 | $461.00 | 37,725.0000 | 258,000,000 | 20.17% | 0.00% |
| Jan. 6, 2026 | WAGNER CHARLES F JR | EVP, CO & FO | M | Common Stock | 9532 | $189.38 | 47,257.0000 | 258,000,000 | 25.27% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 7899 | $445.56 | 67,738.0000 | 258,600,000 | 10.44% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 2320 | $448.78 | 64,266.0000 | 258,600,000 | 3.48% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 5880 | $449.84 | 58,386.0000 | 258,600,000 | 9.15% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 5809 | $451.20 | 52,577.0000 | 258,600,000 | 9.95% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 15681 | $452.20 | 36,896.0000 | 258,600,000 | 29.82% | 0.01% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 10360 | $453.34 | 26,536.0000 | 258,600,000 | 28.08% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 2070 | $455.22 | 24,466.0000 | 258,600,000 | 7.80% | 0.00% |
| Dec. 4, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 1 | $91.05 | 24,467.0000 | 258,600,000 | 0.00% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 4352 | $444.36 | 75,637.0000 | 258,600,000 | 5.44% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 1152 | $447.05 | 66,586.0000 | 258,600,000 | 1.70% | 0.00% |
| Dec. 3, 2025 | WAGNER CHARLES F JR | EVP, CO & FO | S | Common Stock | 7000 | $451.00 | 44,725.0000 | 258,600,000 | 13.53% | 0.00% |
| Dec. 3, 2025 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 347 | $449.00 | 15,306.0000 | 258,600,000 | 2.22% | 0.00% |
| Dec. 4, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 1 | $0.00 | 0.0000 | 258,600,000 | 100.00% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 63781 | $0.00 | 0.0000 | 258,600,000 | 100.00% | 0.02% |
| Dec. 3, 2025 | WAGNER CHARLES F JR | EVP, CO & FO | S | Common Stock | 7000 | $461.00 | 37,725.0000 | 258,600,000 | 15.65% | 0.00% |
| Dec. 3, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 4500 | $449.99 | 46,793.0000 | 258,600,000 | 8.77% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 63781 | $86.52 | 88,247.0000 | 258,600,000 | 260.69% | 0.02% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 4469 | $440.40 | 83,778.0000 | 258,600,000 | 5.06% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 1320 | $441.26 | 82,458.0000 | 258,600,000 | 1.58% | 0.00% |
| Dec. 3, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 2469 | $443.21 | 79,989.0000 | 258,600,000 | 2.99% | 0.00% |
| Nov. 19, 2025 | CARNEY LLOYD | Director | G | Common Stock | 800 | $0.00 | 6,315.0000 | 258,600,000 | 11.24% | 0.00% |
| Nov. 17, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 2500 | $434.58 | 16,852.0000 | 258,600,000 | 12.92% | 0.00% |
| Nov. 13, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 19688 | $0.00 | 13,836.0000 | 258,600,000 | 58.73% | 0.01% |
| Nov. 13, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 19688 | $91.05 | 44,154.0000 | 258,600,000 | 80.47% | 0.01% |
| Nov. 13, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 18528 | $440.22 | 25,626.0000 | 258,600,000 | 41.96% | 0.01% |
| Nov. 13, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 1160 | $441.05 | 24,466.0000 | 258,600,000 | 4.53% | 0.00% |
| Nov. 14, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 13835 | $91.05 | 38,301.0000 | 258,600,000 | 56.55% | 0.01% |
| Nov. 14, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 39769 | $86.52 | 78,070.0000 | 258,600,000 | 103.83% | 0.02% |
| Nov. 14, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 32234 | $440.30 | 45,836.0000 | 258,600,000 | 41.29% | 0.01% |
| Nov. 14, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 21330 | $441.35 | 24,506.0000 | 258,600,000 | 46.54% | 0.01% |
| Nov. 14, 2025 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 40 | $442.00 | 24,466.0000 | 258,600,000 | 0.16% | 0.00% |
| Nov. 14, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 13835 | $0.00 | 1.0000 | 258,600,000 | 99.99% | 0.01% |
| Nov. 14, 2025 | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 39769 | $0.00 | 63,781.0000 | 258,600,000 | 38.41% | 0.02% |
| Oct. 15, 2025 | Upadhyay Suketu | Director | A | Deferred Stock Units | 87 | $410.31 | 2,638.3320 | 258,600,000 | 3.40% | 0.00% |
| Oct. 15, 2025 | SACHS BRUCE I | Director | A | Deferred Stock Units | 116 | $410.31 | 15,457.4330 | 258,600,000 | 0.75% | 0.00% |
| Oct. 1, 2025 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1259 | $400.00 | 16,347.0000 | 258,600,000 | 7.15% | 0.00% |
| Oct. 2, 2025 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 694 | $404.21 | 15,653.0000 | 258,600,000 | 4.25% | 0.00% |
| Aug. 27, 2025 | Bhatia Sangeeta N. | Director | S | Common Stock | 266 | $386.69 | 4,565.0000 | 257,899,999 | 5.51% | 0.00% |
| Aug. 6, 2025 | Kewalramani Reshma | CEO & President | P | Common Stock | 4290 | $389.08 | 110,258.0000 | 257,899,999 | 4.05% | 0.00% |
| Aug. 6, 2025 | Kewalramani Reshma | CEO & President | P | Common Stock | 5710 | $389.95 | 115,968.0000 | 257,899,999 | 5.18% | 0.00% |
| Aug. 6, 2025 | SACHS BRUCE I | Director | P | Common Stock | 1634 | $389.36 | 41,634.0000 | 257,899,999 | 4.09% | 0.00% |
| Aug. 6, 2025 | SACHS BRUCE I | Director | P | Common Stock | 3366 | $389.84 | 45,000.0000 | 257,899,999 | 8.08% | 0.00% |
| July 15, 2025 | SACHS BRUCE I | Director | A | Deferred Stock Units | 101 | $469.34 | 15,341.6670 | 257,899,999 | 0.66% | 0.00% |
| July 15, 2025 | Upadhyay Suketu | Director | A | Deferred Stock Units | 76 | $469.34 | 2,551.5070 | 257,899,999 | 3.07% | 0.00% |
| July 1, 2025 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 37243 | $450.23 | 63,508.0000 | 257,899,999 | 36.97% | 0.01% |
| May 15, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 52 | $424.69 | 23,281.0000 | 257,899,999 | 0.22% | 0.00% |
| May 13, 2025 | Arbuckle Stuart A | EVP, COO | A | Common Stock | 37622 | $0.00 | 100,751.0000 | 257,899,999 | 59.60% | 0.01% |
| May 1, 2025 | Thornberry Nancy | Director | A | Stock Option (Right to Buy) | 1199 | $0.00 | 1,199.0000 | 257,899,999 | 9999.99% | 0.00% |
| May 2, 2025 | Bhatia Sangeeta N. | Director | S | Common Stock | 400 | $505.86 | 4,831.0000 | 257,899,999 | 7.65% | 0.00% |
| May 1, 2025 | Bhatia Sangeeta N. | Director | A | Common Stock | 796 | $0.00 | 5,231.0000 | 257,899,999 | 17.95% | 0.00% |
| May 1, 2025 | CARNEY LLOYD | Director | A | Common Stock | 796 | $0.00 | 7,115.0000 | 257,899,999 | 12.60% | 0.00% |
| May 1, 2025 | Garber Alan M | Director | A | Stock Option (Right to Buy) | 1199 | $0.00 | 1,199.0000 | 257,899,999 | 9999.99% | 0.00% |
| May 1, 2025 | Garber Alan M | Director | A | Common Stock | 398 | $0.00 | 6,872.0000 | 257,899,999 | 6.15% | 0.00% |
| May 1, 2025 | Lagarde Michel | Director | A | Stock Option (Right to Buy) | 2398 | $0.00 | 2,398.0000 | 257,899,999 | 9999.99% | 0.00% |
| May 1, 2025 | MCKENZIE DIANA | Director | A | Deferred Stock Units | 1001 | $0.00 | 6,991.4830 | 257,899,999 | 16.71% | 0.00% |
| May 1, 2025 | MCKENZIE DIANA | Director | D | Common Stock | 1001 | $0.00 | 2,438.0000 | 257,899,999 | 29.11% | 0.00% |
| May 1, 2025 | MCKENZIE DIANA | Director | A | Common Stock | 796 | $0.00 | 3,439.0000 | 257,899,999 | 30.12% | 0.00% |
| May 1, 2025 | SACHS BRUCE I | Director | A | Stock Option (Right to Buy) | 2398 | $0.00 | 2,398.0000 | 257,899,999 | 9999.99% | 0.00% |
| May 1, 2025 | Schneider Jennifer | Director | A | Common Stock | 796 | $0.00 | 1,718.0000 | 257,899,999 | 86.33% | 0.00% |
| May 1, 2025 | Upadhyay Suketu | Director | A | Common Stock | 796 | $0.00 | 3,355.0000 | 257,899,999 | 31.11% | 0.00% |
| May 1, 2025 | Thornberry Nancy | Director | A | Common Stock | 398 | $0.00 | 2,035.0000 | 257,899,999 | 24.31% | 0.00% |
| May 1, 2025 | Upadhyay Suketu | Director | A | Deferred Stock Units | 1001 | $0.00 | 2,475.6030 | 257,899,999 | 67.88% | 0.00% |
| May 1, 2025 | Upadhyay Suketu | Director | D | Common Stock | 1001 | $0.00 | 2,354.0000 | 257,899,999 | 29.84% | 0.00% |
| April 15, 2025 | Upadhyay Suketu | Director | A | Deferred Stock Units | 72 | $497.51 | 1,474.6030 | 257,899,999 | 5.10% | 0.00% |
| April 15, 2025 | SACHS BRUCE I | Director | A | Deferred Stock Units | 95 | $497.51 | 15,240.4610 | 257,899,999 | 0.63% | 0.00% |
| March 13, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 3231 | $510.00 | 23,281.0000 | 257,899,999 | 12.19% | 0.00% |
| March 10, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 3231 | $500.00 | 26,512.0000 | 257,899,999 | 10.86% | 0.00% |
| March 10, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 3242 | $499.99 | 51,239.0000 | 257,899,999 | 5.95% | 0.00% |
| March 10, 2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3298 | $500.00 | 51,671.0000 | 257,899,999 | 6.00% | 0.00% |
| March 4, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 4058 | $485.49 | 54,481.0000 | 257,899,999 | 6.93% | 0.00% |
| March 3, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 3231 | $490.00 | 29,743.0000 | 257,899,999 | 9.80% | 0.00% |
| Feb. 27, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 530 | $475.34 | 58,539.0000 | 257,899,999 | 0.90% | 0.00% |
| Feb. 26, 2025 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 3703 | $479.61 | 69,372.0000 | 257,899,999 | 5.07% | 0.00% |
| Feb. 26, 2025 | Kewalramani Reshma | CEO & President | F | Common Stock | 14079 | $479.61 | 105,915.0000 | 257,899,999 | 11.73% | 0.01% |
| Feb. 26, 2025 | Bozic Carmen | EVP and CMO | F | Common Stock | 4962 | $479.61 | 32,669.0000 | 257,899,999 | 13.19% | 0.00% |
| Feb. 26, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 2482 | $479.61 | 22,002.0000 | 257,899,999 | 10.14% | 0.00% |
| Feb. 26, 2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 4962 | $479.61 | 54,969.0000 | 257,899,999 | 8.28% | 0.00% |
| Feb. 26, 2025 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 7071 | $479.61 | 63,075.0000 | 257,899,999 | 10.08% | 0.00% |
| Feb. 26, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 1241 | $479.61 | 7,845.0000 | 257,899,999 | 13.66% | 0.00% |
| Feb. 26, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | F | Common Stock | 5954 | $479.61 | 34,246.0000 | 257,899,999 | 14.81% | 0.00% |
| Feb. 27, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 1272 | $480.00 | 32,974.0000 | 257,899,999 | 3.71% | 0.00% |
| Feb. 27, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 2650 | $475.34 | 19,352.0000 | 257,899,999 | 12.04% | 0.00% |
| Feb. 26, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 4962 | $479.61 | 59,069.0000 | 257,899,999 | 7.75% | 0.00% |
| Feb. 24, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | F | Common Stock | 3971 | $483.28 | 41,048.0000 | 257,899,999 | 8.82% | 0.00% |
| Feb. 24, 2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 3310 | $483.28 | 59,931.0000 | 257,899,999 | 5.23% | 0.00% |
| Feb. 24, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 3310 | $483.28 | 64,385.0000 | 257,899,999 | 4.89% | 0.00% |
| Feb. 25, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 354 | $480.95 | 64,031.0000 | 257,899,999 | 0.55% | 0.00% |
| Feb. 24, 2025 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2470 | $483.28 | 73,075.0000 | 257,899,999 | 3.27% | 0.00% |
| Feb. 24, 2025 | Kewalramani Reshma | CEO & President | F | Common Stock | 9386 | $483.28 | 119,994.0000 | 257,899,999 | 7.25% | 0.00% |
| Feb. 24, 2025 | Bozic Carmen | EVP and CMO | F | Common Stock | 3310 | $483.28 | 37,631.0000 | 257,899,999 | 8.08% | 0.00% |
| Feb. 24, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1656 | $483.28 | 26,251.0000 | 257,899,999 | 5.93% | 0.00% |
| Feb. 25, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 1767 | $480.95 | 24,484.0000 | 257,899,999 | 6.73% | 0.00% |
| Feb. 24, 2025 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 4716 | $483.28 | 70,146.0000 | 257,899,999 | 6.30% | 0.00% |
| Feb. 24, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 828 | $483.28 | 9,970.0000 | 257,899,999 | 7.67% | 0.00% |
| Feb. 25, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 884 | $480.95 | 9,086.0000 | 257,899,999 | 8.87% | 0.00% |
| Feb. 25, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 848 | $480.95 | 40,200.0000 | 257,899,999 | 2.07% | 0.00% |
| Feb. 20, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 1111 | $480.00 | 45,019.0000 | 257,899,999 | 2.41% | 0.00% |
| Feb. 14, 2025 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2139 | $463.46 | 75,545.0000 | 257,899,999 | 2.75% | 0.00% |
| Feb. 14, 2025 | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 6066 | $463.46 | 24,466.0000 | 257,899,999 | 19.87% | 0.00% |
| Feb. 14, 2025 | Kewalramani Reshma | CEO & President | F | Common Stock | 6553 | $463.46 | 129,380.0000 | 257,899,999 | 4.82% | 0.00% |
| Feb. 14, 2025 | Bozic Carmen | EVP and CMO | F | Common Stock | 1912 | $463.46 | 40,941.0000 | 257,899,999 | 4.46% | 0.00% |
| Feb. 14, 2025 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1504 | $463.46 | 19,263.0000 | 257,899,999 | 7.24% | 0.00% |
| Feb. 14, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2293 | $463.46 | 67,939.0000 | 257,899,999 | 3.26% | 0.00% |
| Feb. 18, 2025 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 1657 | $455.06 | 17,606.0000 | 257,899,999 | 8.60% | 0.00% |
| Feb. 14, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1529 | $463.46 | 27,907.0000 | 257,899,999 | 5.19% | 0.00% |
| Feb. 14, 2025 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 2724 | $463.46 | 74,862.0000 | 257,899,999 | 3.51% | 0.00% |
| Feb. 14, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 564 | $463.46 | 11,469.0000 | 257,899,999 | 4.69% | 0.00% |
| Feb. 18, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 671 | $455.06 | 10,798.0000 | 257,899,999 | 5.85% | 0.00% |
| Feb. 14, 2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 2293 | $463.46 | 63,241.0000 | 257,899,999 | 3.50% | 0.00% |
| Feb. 14, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | F | Common Stock | 2293 | $463.46 | 46,130.0000 | 257,899,999 | 4.74% | 0.00% |
| Feb. 18, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 244 | $455.06 | 67,695.0000 | 257,899,999 | 0.36% | 0.00% |
| Feb. 12, 2025 | Arbuckle Stuart A | EVP, COO | A | Common Stock | 7903 | $0.00 | 77,586.0000 | 257,899,999 | 11.34% | 0.00% |
| Feb. 12, 2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 6655 | $0.00 | 65,534.0000 | 257,899,999 | 11.30% | 0.00% |
| Feb. 12, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 6211 | $0.00 | 70,232.0000 | 257,899,999 | 9.70% | 0.00% |
| Feb. 12, 2025 | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 7209 | $0.00 | 33,057.0000 | 257,899,999 | 27.89% | 0.00% |
| Feb. 13, 2025 | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 2525 | $450.83 | 30,532.0000 | 257,899,999 | 7.64% | 0.00% |
| Feb. 12, 2025 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 6211 | $0.00 | 77,684.0000 | 257,899,999 | 8.69% | 0.00% |
| Feb. 12, 2025 | Kewalramani Reshma | CEO & President | A | Common Stock | 19015 | $0.00 | 135,933.0000 | 257,899,999 | 16.26% | 0.01% |
| Feb. 12, 2025 | Bozic Carmen | EVP and CMO | A | Common Stock | 5546 | $0.00 | 42,853.0000 | 257,899,999 | 14.87% | 0.00% |
| Feb. 12, 2025 | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 4437 | $0.00 | 20,767.0000 | 257,899,999 | 27.17% | 0.00% |
| Feb. 12, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 6211 | $0.00 | 29,436.0000 | 257,899,999 | 26.74% | 0.00% |
| Feb. 12, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 2080 | $0.00 | 12,033.0000 | 257,899,999 | 20.90% | 0.00% |
| Feb. 12, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 5324 | $0.00 | 48,423.0000 | 257,899,999 | 12.35% | 0.00% |
| Feb. 11, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 1376 | $459.83 | 9,953.0000 | 257,899,999 | 12.15% | 0.00% |
| Feb. 10, 2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 2649 | $467.98 | 58,879.0000 | 257,899,999 | 4.31% | 0.00% |
| Feb. 10, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2143 | $467.98 | 64,331.0000 | 257,899,999 | 3.22% | 0.00% |
| Feb. 11, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 310 | $459.83 | 64,021.0000 | 257,899,999 | 0.48% | 0.00% |
| Feb. 10, 2025 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2056 | $467.98 | 71,473.0000 | 257,899,999 | 2.80% | 0.00% |
| Feb. 10, 2025 | Kewalramani Reshma | CEO & President | F | Common Stock | 8300 | $467.98 | 116,918.0000 | 257,899,999 | 6.63% | 0.00% |
| Feb. 10, 2025 | Bozic Carmen | EVP and CMO | F | Common Stock | 2142 | $467.98 | 37,307.0000 | 257,899,999 | 5.43% | 0.00% |
| Feb. 10, 2025 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1632 | $467.98 | 19,763.0000 | 257,899,999 | 7.63% | 0.00% |
| Feb. 11, 2025 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 3433 | $459.87 | 16,330.0000 | 257,899,999 | 17.37% | 0.00% |
| Feb. 10, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 876 | $467.98 | 24,972.0000 | 257,899,999 | 3.39% | 0.00% |
| Feb. 11, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 1747 | $459.83 | 23,225.0000 | 257,899,999 | 7.00% | 0.00% |
| Feb. 10, 2025 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 3220 | $467.98 | 69,683.0000 | 257,899,999 | 4.42% | 0.00% |
| Feb. 10, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | F | Common Stock | 2142 | $467.98 | 43,099.0000 | 257,899,999 | 4.73% | 0.00% |
| Feb. 10, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 591 | $467.98 | 11,329.0000 | 257,899,999 | 4.96% | 0.00% |
| Feb. 4, 2025 | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 4744 | $0.00 | 21,395.0000 | 257,899,999 | 28.49% | 0.00% |
| Feb. 4, 2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 10262 | $0.00 | 54,414.0000 | 257,899,999 | 23.24% | 0.00% |
| Feb. 4, 2025 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 7114 | $0.00 | 61,528.0000 | 257,899,999 | 13.07% | 0.00% |
| Feb. 4, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 10262 | $0.00 | 59,360.0000 | 257,899,999 | 20.90% | 0.00% |
| Feb. 4, 2025 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 7114 | $0.00 | 66,474.0000 | 257,899,999 | 11.98% | 0.00% |
| Feb. 4, 2025 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 8210 | $0.00 | 66,415.0000 | 257,899,999 | 14.11% | 0.00% |
| Feb. 4, 2025 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 7114 | $0.00 | 73,529.0000 | 257,899,999 | 10.71% | 0.00% |
| Feb. 4, 2025 | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 15414 | $0.00 | 25,848.0000 | 257,899,999 | 147.73% | 0.01% |
| Feb. 4, 2025 | Kewalramani Reshma | CEO & President | A | Common Stock | 29118 | $0.00 | 104,890.0000 | 257,899,999 | 38.43% | 0.01% |
| Feb. 4, 2025 | Kewalramani Reshma | CEO & President | A | Common Stock | 20328 | $0.00 | 125,218.0000 | 257,899,999 | 19.38% | 0.01% |
| Feb. 4, 2025 | Bozic Carmen | EVP and CMO | A | Common Stock | 10262 | $0.00 | 33,521.0000 | 257,899,999 | 44.12% | 0.00% |
| Feb. 4, 2025 | Bozic Carmen | EVP and CMO | A | Common Stock | 5928 | $0.00 | 39,449.0000 | 257,899,999 | 17.68% | 0.00% |
| Feb. 4, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 5132 | $0.00 | 21,104.0000 | 257,899,999 | 32.13% | 0.00% |
| Feb. 4, 2025 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 4744 | $0.00 | 25,848.0000 | 257,899,999 | 22.48% | 0.00% |
| Feb. 4, 2025 | Arbuckle Stuart A | EVP, COO | A | Common Stock | 14624 | $0.00 | 64,455.0000 | 257,899,999 | 29.35% | 0.01% |
| Feb. 4, 2025 | Arbuckle Stuart A | EVP, COO | A | Common Stock | 8448 | $0.00 | 72,903.0000 | 257,899,999 | 13.11% | 0.00% |
| Feb. 4, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 2566 | $0.00 | 10,066.0000 | 257,899,999 | 34.21% | 0.00% |
| Feb. 4, 2025 | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 1854 | $0.00 | 11,920.0000 | 257,899,999 | 18.42% | 0.00% |
| Feb. 4, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 12314 | $0.00 | 38,127.0000 | 257,899,999 | 47.70% | 0.00% |
| Feb. 4, 2025 | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 7114 | $0.00 | 45,241.0000 | 257,899,999 | 18.66% | 0.00% |
| Jan. 15, 2025 | SACHS BRUCE I | Director | A | Deferred Stock Units | 112 | $420.31 | 15,144.9860 | 257,899,999 | 0.74% | 0.00% |
| Nov. 15, 2024 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 15 | $478.56 | 25,813.0000 | 261,000,000 | 0.06% | 0.00% |
| Nov. 11, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3000 | $518.27 | 44,137.0000 | 261,000,000 | 6.36% | 0.00% |
| Nov. 8, 2024 | Kewalramani Reshma | CEO & President | S | Common Stock | 15198 | $515.00 | 75,772.0000 | 261,000,000 | 16.71% | 0.01% |
| Oct. 15, 2024 | SACHS BRUCE I | Director | A | Deferred Stock Units | 90 | $484.39 | 15,033.3320 | 261,000,000 | 0.60% | 0.00% |
| Oct. 2, 2024 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 999 | $461.66 | 16,651.0000 | 261,000,000 | 5.66% | 0.00% |
| Oct. 1, 2024 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 630 | $466.84 | 17,650.0000 | 261,000,000 | 3.45% | 0.00% |
| Aug. 30, 2024 | Bhatia Sangeeta N. | Director | S | Common Stock | 646 | $500.00 | 4,435.0000 | 260,500,000 | 12.71% | 0.00% |
| Aug. 30, 2024 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 3784 | $499.00 | 10,434.0000 | 260,500,000 | 26.61% | 0.00% |
| Aug. 30, 2024 | Bhatia Sangeeta N. | Director | M | Common Stock | 646 | $152.74 | 5,081.0000 | 260,500,000 | 14.57% | 0.00% |
| Aug. 30, 2024 | Bhatia Sangeeta N. | Director | M | Stock Option (Right to Buy) | 646 | $0.00 | 0.0000 | 260,500,000 | 100.00% | 0.00% |
| Aug. 8, 2024 | Bhatia Sangeeta N. | Director | M | Stock Option (Right to Buy) | 1292 | $0.00 | 646.0000 | 260,500,000 | 66.67% | 0.00% |
| Aug. 8, 2024 | Bhatia Sangeeta N. | Director | M | Common Stock | 1292 | $152.74 | 5,727.0000 | 260,500,000 | 29.13% | 0.00% |
| Aug. 8, 2024 | Bhatia Sangeeta N. | Director | S | Common Stock | 1292 | $466.29 | 4,435.0000 | 260,500,000 | 22.56% | 0.00% |
| Aug. 7, 2024 | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $476.75 | 23,259.0000 | 260,500,000 | 8.93% | 0.00% |
| Aug. 1, 2024 | SACHS BRUCE I | Director | S | Common Stock | 5295 | $508.00 | 40,000.0000 | 260,500,000 | 11.69% | 0.00% |
| Aug. 1, 2024 | SACHS BRUCE I | Director | M | Common Stock | 5295 | $125.71 | 45,295.0000 | 260,500,000 | 13.24% | 0.00% |
| Aug. 1, 2024 | SACHS BRUCE I | Director | M | Stock Option (Right to Buy) | 5295 | $0.00 | 0.0000 | 260,500,000 | 100.00% | 0.00% |
| July 30, 2024 | Kewalramani Reshma | CEO & President | S | Common Stock | 15202 | $505.00 | 90,970.0000 | 260,500,000 | 14.32% | 0.01% |
| July 24, 2024 | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $488.46 | 25,539.0000 | 260,500,000 | 8.20% | 0.00% |
| July 22, 2024 | Kewalramani Reshma | CEO & President | S | Common Stock | 15202 | $497.00 | 106,172.0000 | 260,500,000 | 12.52% | 0.01% |
| July 15, 2024 | SACHS BRUCE I | Director | A | Deferred Stock Units | 89 | $490.12 | 14,943.0120 | 260,500,000 | 0.60% | 0.00% |
| July 10, 2024 | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $487.34 | 27,819.0000 | 260,500,000 | 7.58% | 0.00% |
| June 26, 2024 | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $471.72 | 30,099.0000 | 260,500,000 | 7.04% | 0.00% |
| June 12, 2024 | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $478.00 | 32,379.0000 | 260,500,000 | 6.58% | 0.00% |
| June 11, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 6824 | $481.96 | 23,260.0000 | 260,500,000 | 22.68% | 0.00% |
| June 12, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 7288 | $478.00 | 15,972.0000 | 260,500,000 | 31.33% | 0.00% |
| June 5, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | G | Common Stock | 4600 | $0.00 | 58,172.0000 | 260,500,000 | 7.33% | 0.00% |
| June 3, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3250 | $460.00 | 47,137.0000 | 260,500,000 | 6.45% | 0.00% |
| June 3, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 2175 | $460.00 | 49,098.0000 | 260,500,000 | 4.24% | 0.00% |
| May 30, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 2350 | $439.11 | 53,523.0000 | 260,500,000 | 4.21% | 0.00% |
| May 31, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 2250 | $445.00 | 51,273.0000 | 260,500,000 | 4.20% | 0.00% |
| May 29, 2024 | Bozic Carmen | EVP and CMO | S | Common Stock | 2280 | $445.56 | 34,659.0000 | 260,500,000 | 6.17% | 0.00% |
| May 28, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3250 | $454.79 | 50,387.0000 | 260,500,000 | 6.06% | 0.00% |
| May 24, 2024 | Kewalramani Reshma | CEO & President | S | Common Stock | 1565 | $457.00 | 121,374.0000 | 260,500,000 | 1.27% | 0.00% |
| May 24, 2024 | Kewalramani Reshma | CEO & President | M | Common Stock | 1565 | $187.53 | 122,939.0000 | 260,500,000 | 1.29% | 0.00% |
| May 24, 2024 | Kewalramani Reshma | CEO & President | M | Stock Option (Right to Buy) | 1565 | $0.00 | 0.0000 | 260,500,000 | 100.00% | 0.00% |
| May 22, 2024 | SACHS BRUCE I | Director | S | Common Stock | 7073 | $448.00 | 40,000.0000 | 260,500,000 | 15.03% | 0.00% |
| May 22, 2024 | SACHS BRUCE I | Director | M | Stock Option (Right to Buy) | 7073 | $0.00 | 0.0000 | 260,500,000 | 100.00% | 0.00% |
| May 22, 2024 | SACHS BRUCE I | Director | M | Common Stock | 7073 | $93.51 | 47,073.0000 | 260,500,000 | 17.68% | 0.00% |
| May 20, 2024 | Kewalramani Reshma | CEO & President | S | Common Stock | 15202 | $447.00 | 121,374.0000 | 260,500,000 | 11.13% | 0.01% |
| May 15, 2024 | Arbuckle Stuart A | EVP, COO | S | Common Stock | 69 | $430.93 | 49,831.0000 | 260,500,000 | 0.14% | 0.00% |
| May 15, 2024 | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 54 | $430.93 | 25,813.0000 | 260,500,000 | 0.21% | 0.00% |
| May 15, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 32 | $430.93 | 62,772.0000 | 260,500,000 | 0.05% | 0.00% |
| May 15, 2024 | Schneider Jennifer | Director | A | Common Stock | 922 | $0.00 | 922.0000 | 260,500,000 | 9999.99% | 0.00% |
| May 14, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 14112 | $0.00 | 30,084.0000 | 260,500,000 | 88.35% | 0.01% |
| May 1, 2024 | SACHS BRUCE I | Director | A | Stock Option (Right to Buy) | 3142 | $0.00 | 3,142.0000 | 260,500,000 | 9999.99% | 0.00% |
| May 2, 2024 | Bhatia Sangeeta N. | Director | S | Common Stock | 467 | $402.95 | 4,435.0000 | 260,500,000 | 9.53% | 0.00% |
| May 1, 2024 | Bhatia Sangeeta N. | Director | A | Common Stock | 1001 | $0.00 | 4,902.0000 | 260,500,000 | 25.66% | 0.00% |
| May 1, 2024 | CARNEY LLOYD | Director | A | Common Stock | 1001 | $0.00 | 6,319.0000 | 260,500,000 | 18.82% | 0.00% |
| May 1, 2024 | Garber Alan M | Director | A | Stock Option (Right to Buy) | 3142 | $0.00 | 3,142.0000 | 260,500,000 | 9999.99% | 0.00% |
| May 1, 2024 | Kearney Terrence C | Director | A | Stock Option (Right to Buy) | 3142 | $0.00 | 3,142.0000 | 260,500,000 | 9999.99% | 0.00% |
| May 1, 2024 | Lagarde Michel | Director | A | Stock Option (Right to Buy) | 3142 | $0.00 | 3,142.0000 | 260,500,000 | 9999.99% | 0.00% |
| May 1, 2024 | MCKENZIE DIANA | Director | A | Deferred Stock Units | 1168 | $0.00 | 5,990.4830 | 260,500,000 | 24.22% | 0.00% |
| May 1, 2024 | MCKENZIE DIANA | Director | D | Common Stock | 1168 | $0.00 | 2,643.0000 | 260,500,000 | 30.65% | 0.00% |
| May 1, 2024 | MCKENZIE DIANA | Director | A | Common Stock | 1001 | $0.00 | 3,811.0000 | 260,500,000 | 35.62% | 0.00% |
| May 1, 2024 | Thornberry Nancy | Director | A | Stock Option (Right to Buy) | 1571 | $0.00 | 1,571.0000 | 260,500,000 | 9999.99% | 0.00% |
| May 1, 2024 | Thornberry Nancy | Director | A | Common Stock | 501 | $0.00 | 1,637.0000 | 260,500,000 | 44.10% | 0.00% |
| May 1, 2024 | Upadhyay Suketu | Director | A | Deferred Stock Units | 1168 | $0.00 | 1,402.9960 | 260,500,000 | 497.03% | 0.00% |
| May 1, 2024 | Upadhyay Suketu | Director | D | Common Stock | 1168 | $0.00 | 2,559.0000 | 260,500,000 | 31.34% | 0.00% |
| May 1, 2024 | Upadhyay Suketu | Director | A | Common Stock | 1001 | $0.00 | 3,727.0000 | 260,500,000 | 36.72% | 0.00% |
| April 15, 2024 | SACHS BRUCE I | Director | A | Deferred Stock Units | 109 | $399.58 | 14,853.7480 | 260,500,000 | 0.74% | 0.00% |
| April 2, 2024 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 240 | $419.00 | 7,500.0000 | 260,500,000 | 3.10% | 0.00% |
| April 1, 2024 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 225 | $418.10 | 7,740.0000 | 260,500,000 | 2.82% | 0.00% |
| Feb. 26, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 354 | $425.70 | 55,804.0000 | 260,500,000 | 0.63% | 0.00% |
| Feb. 23, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2469 | $431.79 | 65,776.0000 | 260,500,000 | 3.62% | 0.00% |
| Feb. 26, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 3004 | $425.70 | 62,772.0000 | 260,500,000 | 4.57% | 0.00% |
| Feb. 23, 2024 | Kewalramani Reshma | CEO & President | F | Common Stock | 9386 | $431.79 | 136,507.0000 | 260,500,000 | 6.43% | 0.00% |
| Feb. 23, 2024 | Bozic Carmen | EVP and CMO | F | Common Stock | 3309 | $431.79 | 36,939.0000 | 260,500,000 | 8.22% | 0.00% |
| Feb. 23, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1654 | $431.79 | 16,855.0000 | 260,500,000 | 8.94% | 0.00% |
| Feb. 26, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 883 | $425.70 | 15,972.0000 | 260,500,000 | 5.24% | 0.00% |
| Feb. 23, 2024 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 4714 | $431.79 | 54,865.0000 | 260,500,000 | 7.91% | 0.00% |
| Feb. 26, 2024 | Arbuckle Stuart A | EVP, COO | S | Common Stock | 5034 | $425.70 | 49,831.0000 | 260,500,000 | 9.18% | 0.00% |
| Feb. 23, 2024 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 828 | $431.79 | 8,848.0000 | 260,500,000 | 8.56% | 0.00% |
| Feb. 26, 2024 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 883 | $425.70 | 7,965.0000 | 260,500,000 | 9.98% | 0.00% |
| Feb. 26, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | S | Common Stock | 4239 | $425.70 | 25,813.0000 | 260,500,000 | 14.11% | 0.00% |
| Feb. 23, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | F | Common Stock | 3970 | $431.79 | 30,052.0000 | 260,500,000 | 11.67% | 0.00% |
| Feb. 23, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 3309 | $431.79 | 53,583.0000 | 260,500,000 | 5.82% | 0.00% |
| Feb. 23, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 3309 | $431.79 | 56,158.0000 | 260,500,000 | 5.56% | 0.00% |
| Feb. 21, 2024 | Arbuckle Stuart A | EVP, COO | S | Common Stock | 3603 | $421.77 | 59,579.0000 | 260,500,000 | 5.70% | 0.00% |
| Feb. 21, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 360 | $421.77 | 59,467.0000 | 260,500,000 | 0.60% | 0.00% |
| Feb. 21, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 3191 | $421.77 | 68,245.0000 | 260,500,000 | 4.47% | 0.00% |
| Feb. 21, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 1201 | $421.77 | 18,509.0000 | 260,500,000 | 6.09% | 0.00% |
| Feb. 21, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | S | Common Stock | 3002 | $421.77 | 34,022.0000 | 260,500,000 | 8.11% | 0.00% |
| Feb. 16, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1501 | $424.01 | 21,636.0000 | 260,500,000 | 6.49% | 0.00% |
| Feb. 16, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 3750 | $424.01 | 59,704.0000 | 260,500,000 | 5.91% | 0.00% |
| Feb. 20, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 2812 | $420.58 | 56,892.0000 | 260,500,000 | 4.71% | 0.00% |
| Feb. 16, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 4499 | $424.01 | 63,680.0000 | 260,500,000 | 6.60% | 0.00% |
| Feb. 20, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 3373 | $420.58 | 60,307.0000 | 260,500,000 | 5.30% | 0.00% |
| Feb. 20, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 480 | $420.79 | 59,827.0000 | 260,500,000 | 0.80% | 0.00% |
| Feb. 16, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 3498 | $424.01 | 78,313.0000 | 260,500,000 | 4.28% | 0.00% |
| Feb. 20, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2623 | $420.58 | 75,690.0000 | 260,500,000 | 3.35% | 0.00% |
| Feb. 20, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 4254 | $420.79 | 71,436.0000 | 260,500,000 | 5.62% | 0.00% |
| Feb. 20, 2024 | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 4118 | $420.58 | 14,218.0000 | 260,500,000 | 22.46% | 0.00% |
| Feb. 16, 2024 | Kewalramani Reshma | CEO & President | F | Common Stock | 9359 | $424.01 | 152,912.0000 | 260,500,000 | 5.77% | 0.00% |
| Feb. 20, 2024 | Kewalramani Reshma | CEO & President | F | Common Stock | 7019 | $420.58 | 145,893.0000 | 260,500,000 | 4.59% | 0.00% |
| Feb. 16, 2024 | Bozic Carmen | EVP and CMO | F | Common Stock | 3750 | $424.01 | 43,060.0000 | 260,500,000 | 8.01% | 0.00% |
| Feb. 20, 2024 | Bozic Carmen | EVP and CMO | F | Common Stock | 2812 | $420.58 | 40,248.0000 | 260,500,000 | 6.53% | 0.00% |
| Feb. 20, 2024 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 3373 | $420.58 | 67,986.0000 | 260,500,000 | 4.73% | 0.00% |
| Feb. 20, 2024 | Arbuckle Stuart A | EVP, COO | S | Common Stock | 4804 | $420.79 | 63,182.0000 | 260,500,000 | 7.07% | 0.00% |
| Feb. 16, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | F | Common Stock | 3750 | $424.01 | 43,838.0000 | 260,500,000 | 7.88% | 0.00% |
| Feb. 20, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | F | Common Stock | 2812 | $420.58 | 41,026.0000 | 260,500,000 | 6.41% | 0.00% |
| Feb. 20, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | S | Common Stock | 4002 | $420.79 | 37,024.0000 | 260,500,000 | 9.75% | 0.00% |
| Feb. 20, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1125 | $420.58 | 20,511.0000 | 260,500,000 | 5.20% | 0.00% |
| Feb. 20, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 801 | $420.79 | 19,710.0000 | 260,500,000 | 3.91% | 0.00% |
| Feb. 16, 2024 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 4499 | $424.01 | 71,359.0000 | 260,500,000 | 5.93% | 0.00% |
| Feb. 14, 2024 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 4356 | $419.04 | 22,991.0000 | 260,500,000 | 15.93% | 0.00% |
| Feb. 15, 2024 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 4655 | $419.16 | 18,336.0000 | 260,500,000 | 20.25% | 0.00% |
| Feb. 13, 2024 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 737 | $419.13 | 27,347.0000 | 260,500,000 | 2.62% | 0.00% |
| Feb. 12, 2024 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 2009 | $419.22 | 28,731.0000 | 260,500,000 | 6.54% | 0.00% |
| Feb. 12, 2024 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 647 | $420.39 | 28,084.0000 | 260,500,000 | 2.25% | 0.00% |
| Feb. 9, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F | Common Stock | 2100 | $422.74 | 68,493.0000 | 260,500,000 | 2.97% | 0.00% |
| Feb. 9, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | F | Common Stock | 2607 | $422.74 | 63,454.0000 | 260,500,000 | 3.95% | 0.00% |
| Feb. 12, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S | Common Stock | 3222 | $420.24 | 81,811.0000 | 260,500,000 | 3.79% | 0.00% |
| Feb. 12, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S | Common Stock | 314 | $420.24 | 68,179.0000 | 260,500,000 | 0.46% | 0.00% |
| Feb. 9, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F | Common Stock | 2022 | $422.74 | 85,033.0000 | 260,500,000 | 2.32% | 0.00% |
| Feb. 12, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | S | Common Stock | 3145 | $420.24 | 47,588.0000 | 260,500,000 | 6.20% | 0.00% |
| Feb. 9, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | F | Common Stock | 2099 | $422.74 | 50,733.0000 | 260,500,000 | 3.97% | 0.00% |
| Feb. 12, 2024 | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 1374 | $420.24 | 9,676.0000 | 260,500,000 | 12.43% | 0.00% |
| Feb. 9, 2024 | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 591 | $422.74 | 11,050.0000 | 260,500,000 | 5.08% | 0.00% |
| Feb. 12, 2024 | Arbuckle Stuart A | EVP, COO | S | Common Stock | 4295 | $420.24 | 75,858.0000 | 260,500,000 | 5.36% | 0.00% |
| Feb. 9, 2024 | Arbuckle Stuart A | EVP, COO | F | Common Stock | 3177 | $422.74 | 80,153.0000 | 260,500,000 | 3.81% | 0.00% |
| Feb. 12, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 913 | $420.24 | 23,137.0000 | 260,500,000 | 3.80% | 0.00% |
| Feb. 9, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 832 | $422.74 | 24,050.0000 | 260,500,000 | 3.34% | 0.00% |
| Feb. 12, 2024 | Biller Jonathan | EVP and Chief Legal Officer | S | Common Stock | 1738 | $418.77 | 18,280.0000 | 260,500,000 | 8.68% | 0.00% |
| Feb. 9, 2024 | Biller Jonathan | EVP and Chief Legal Officer | F | Common Stock | 1588 | $422.74 | 20,018.0000 | 260,500,000 | 7.35% | 0.00% |
| Feb. 9, 2024 | Bozic Carmen | EVP and CMO | F | Common Stock | 2100 | $422.74 | 46,810.0000 | 260,500,000 | 4.29% | 0.00% |
| Feb. 9, 2024 | Kewalramani Reshma | CEO & President | F | Common Stock | 8255 | $422.74 | 162,271.0000 | 260,500,000 | 4.84% | 0.00% |
| Feb. 9, 2024 | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 8048 | $422.74 | 30,740.0000 | 260,500,000 | 20.75% | 0.00% |
| Feb. 8, 2024 | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 2698 | $421.73 | 38,788.0000 | 260,500,000 | 6.50% | 0.00% |
| Feb. 6, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 2326 | $0.00 | 16,205.0000 | 260,500,000 | 16.76% | 0.00% |
| Feb. 7, 2024 | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 4743 | $0.00 | 21,606.0000 | 260,500,000 | 28.13% | 0.00% |
| Feb. 6, 2024 | Biller Jonathan | EVP and Chief Legal Officer | A | Common Stock | 6294 | $0.00 | 16,863.0000 | 260,500,000 | 59.55% | 0.00% |
| Feb. 7, 2024 | Bozic Carmen | EVP and CMO | A | Common Stock | 5928 | $0.00 | 48,910.0000 | 260,500,000 | 13.79% | 0.00% |
| Feb. 6, 2024 | Bozic Carmen | EVP and CMO | A | Common Stock | 7866 | $0.00 | 42,982.0000 | 260,500,000 | 22.40% | 0.00% |
| Feb. 6, 2024 | Bozic Carmen | EVP and CMO | A | Common Stock | 5814 | $0.00 | 35,116.0000 | 260,500,000 | 19.84% | 0.00% |
| Feb. 7, 2024 | Kewalramani Reshma | CEO & President | A | Common Stock | 20327 | $0.00 | 170,526.0000 | 260,500,000 | 13.53% | 0.01% |
| Feb. 6, 2024 | Kewalramani Reshma | CEO & President | A | Common Stock | 26972 | $0.00 | 150,199.0000 | 260,500,000 | 21.89% | 0.01% |
| Feb. 6, 2024 | Kewalramani Reshma | CEO & President | A | Common Stock | 14516 | $0.00 | 123,227.0000 | 260,500,000 | 13.35% | 0.01% |
| Feb. 7, 2024 | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 7707 | $0.00 | 41,486.0000 | 260,500,000 | 22.82% | 0.00% |
| Feb. 6, 2024 | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 20452 | $0.00 | 33,779.0000 | 260,500,000 | 153.46% | 0.01% |
| Feb. 6, 2024 | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 10464 | $0.00 | 13,327.0000 | 260,500,000 | 365.49% | 0.00% |
| Feb. 7, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 7114 | $0.00 | 87,055.0000 | 260,500,000 | 8.90% | 0.00% |
| Feb. 6, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 7866 | $0.00 | 79,941.0000 | 260,500,000 | 10.91% | 0.00% |
| Feb. 6, 2024 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A | Common Stock | 5814 | $0.00 | 72,075.0000 | 260,500,000 | 8.77% | 0.00% |
| Feb. 7, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 7114 | $0.00 | 70,593.0000 | 260,500,000 | 11.21% | 0.00% |
| Feb. 6, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 7866 | $0.00 | 63,479.0000 | 260,500,000 | 14.14% | 0.00% |
| Feb. 6, 2024 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A | Common Stock | 6976 | $0.00 | 55,613.0000 | 260,500,000 | 14.34% | 0.00% |
| Feb. 7, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 7114 | $0.00 | 66,061.0000 | 260,500,000 | 12.07% | 0.00% |
| Feb. 6, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 9440 | $0.00 | 58,947.0000 | 260,500,000 | 19.07% | 0.00% |
| Feb. 6, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | A | Common Stock | 5814 | $0.00 | 49,507.0000 | 260,500,000 | 13.31% | 0.00% |
| Feb. 6, 2024 | Arbuckle Stuart A | EVP, COO | A | Common Stock | 6976 | $0.00 | 63,672.0000 | 260,500,000 | 12.30% | 0.00% |
| Feb. 6, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 3934 | $0.00 | 20,139.0000 | 260,500,000 | 24.28% | 0.00% |
| Feb. 6, 2024 | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 2950 | $0.00 | 9,788.0000 | 260,500,000 | 43.14% | 0.00% |
| Feb. 7, 2024 | Arbuckle Stuart A | EVP, COO | A | Common Stock | 8448 | $0.00 | 83,330.0000 | 260,500,000 | 11.28% | 0.00% |
| Feb. 6, 2024 | Arbuckle Stuart A | EVP, COO | A | Common Stock | 11210 | $0.00 | 74,882.0000 | 260,500,000 | 17.61% | 0.00% |
| Feb. 7, 2024 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 4743 | $0.00 | 24,882.0000 | 260,500,000 | 23.55% | 0.00% |
| Feb. 7, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | A | Common Stock | 7114 | $0.00 | 52,832.0000 | 260,500,000 | 15.56% | 0.00% |
| Feb. 6, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | A | Common Stock | 7866 | $0.00 | 45,718.0000 | 260,500,000 | 20.78% | 0.00% |
| Feb. 6, 2024 | ALTSHULER DAVID | EVP, Global Research and CSO | A | Common Stock | 5814 | $0.00 | 37,852.0000 | 260,500,000 | 18.15% | 0.00% |
| Feb. 7, 2024 | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 1853 | $0.00 | 11,641.0000 | 260,500,000 | 18.93% | 0.00% |
| Jan. 12, 2024 | MCKENZIE DIANA | Director | A | Deferred Stock Units | 77 | $432.99 | 4,822.4830 | 260,500,000 | 1.61% | 0.00% |
| Jan. 12, 2024 | SACHS BRUCE I | Director | A | Deferred Stock Units | 101 | $432.99 | 14,744.2580 | 260,500,000 | 0.69% | 0.00% |
| Jan. 8, 2024 | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 6648 | $419.07 | 2,863.0000 | 260,500,000 | 69.90% | 0.00% |
| Jan. 2, 2024 | WAGNER CHARLES F JR | EVP & Chief Financial Officer | S | Common Stock | 3000 | $405.00 | 43,693.0000 | 260,500,000 | 6.42% | 0.00% |